Figure 2. Characterization of demographics. (A) sarcopenia components, (B) and related biomarker, (C) features of elderly with sarcopenia reversal at the end of the intervention. No reversal was defined as the presence of sarcopenia at both baseline and 6-month (n = 51). Reversal group included elderly who had the presence of sarcopenia at baseline and absence of sarcopenia at 6-month (n = 24). Non-sarcopenia was classified as the absence of sarcopenia at both baseline and 6-month (n = 131). CRP = C-reactive protein, TNF-α = tumor necrosis factor alpha, DHEA-S = dehydroepiandrosterone sulfate.